Clinical trial
Molecular Genetic and Pathological Studies of Anal Tumors
NCT00267787 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Genetic and Pathological Studies of Anal Tumors
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- September 30, 2004
- Completion date
- December 31, 2017
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anal cancer, colon cancer, colonic neoplasms, rectal cancer